Terns Pharmaceuticals, Inc. (TERN)
NASDAQ: TERN · Real-Time Price · USD
8.43
+0.20 (2.43%)
At close: Oct 6, 2025, 4:00 PM EDT
8.35
-0.08 (-0.95%)
After-hours: Oct 6, 2025, 4:15 PM EDT
Terns Pharmaceuticals Employees
Terns Pharmaceuticals had 59 employees as of December 31, 2024. The number of employees decreased by 7 or -10.61% compared to the previous year.
Employees
59
Change (1Y)
-7
Growth (1Y)
-10.61%
Revenue / Employee
n/a
Profits / Employee
-$1,555,000
Market Cap
736.84M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 59 | -7 | -10.61% |
Dec 31, 2023 | 66 | 20 | 43.48% |
Dec 31, 2022 | 46 | 5 | 12.20% |
Dec 31, 2021 | 41 | 11 | 36.67% |
Dec 31, 2020 | 30 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
TERN News
- 4 days ago - Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) - GlobeNewsWire
- 26 days ago - Terns Pharmaceuticals, Inc. (TERN) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 4 weeks ago - Terns Pharmaceuticals, Inc. - TERN-701 Investor Educational Webinar Transcript - Seeking Alpha
- 6 weeks ago - Terns Pharmaceuticals to Host an Educational Webinar on TERN-701 for Investors in Advance of Phase 1 Data Expected in Fourth Quarter 2025 - GlobeNewsWire
- 2 months ago - Terns Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Corporate Updates - GlobeNewsWire
- 3 months ago - Terns Pharmaceuticals: A Risky Buy Ahead Of Q4 Obesity, Oncology Catalysts - Seeking Alpha
- 3 months ago - Terns Pharmaceuticals Presents Positive Data from Phase 1 Study of TERN-601 Once-daily Oral GLP-1R Agonist for Treatment of Obesity at 85th Annual American Diabetes Association Scientific Sessions - GlobeNewsWire
- 4 months ago - Terns Pharmaceuticals to Participate in Upcoming June Investor Conferences - GlobeNewsWire